• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

棘白菌素的矛盾活性:一种有限的体外现象?

Paradoxical echinocandin activity: a limited in vitro phenomenon?

作者信息

Wiederhold Nathan P

机构信息

University of Texas at Austin College of Pharmacy, Austin, Texas 78229, USA.

出版信息

Med Mycol. 2009;47 Suppl 1:S369-75. doi: 10.1080/13693780802428542. Epub 2009 Feb 28.

DOI:10.1080/13693780802428542
PMID:19255904
Abstract

The echinocandins have been a welcome addition for the treatment of invasive fungal infections. Despite their excellent safety profile and clinical efficacy, concerns exist regarding an attenuation of activity at higher concentrations, known as the paradoxical effect. In vitro studies have reported this phenomenon against both Candida and Aspergillus species. Recent data have also demonstrated this effect to be species-related and echinocandin specific. Although not completely understood, studies have pointed towards involvement of the protein kinase C cell wall integrity pathway as well as increases in cell wall chitin content as potential mechanisms responsible for this phenomenon. Increases in galactomannan have been reported in vitro and in vivo following echinocandin exposure. Although some in vivo studies of invasive aspergillosis have also reported a paradoxical increase in other markers of invasive disease and fungal burden with echinocandin therapy, these observations are inconsistent. The paradoxical effect has also not been demonstrated clinically. Thus, the clinical implications of the paradoxical attenuation of echinocandin activity at elevated concentrations remain unknown. A complete understanding of this effect may further our knowledge of fungal responses to echinocandin cell wall damage and potentially improve treatment strategies.

摘要

棘白菌素类药物已成为治疗侵袭性真菌感染的一项受欢迎的补充药物。尽管其具有出色的安全性和临床疗效,但对于较高浓度下活性减弱的情况仍存在担忧,这种现象被称为矛盾效应。体外研究已报道了针对念珠菌属和曲霉属的这一现象。近期数据也表明这种效应与菌种相关且具有棘白菌素特异性。尽管尚未完全了解,但研究指出蛋白激酶C细胞壁完整性途径的参与以及细胞壁几丁质含量的增加是导致这一现象的潜在机制。在棘白菌素暴露后,体外和体内均已报道半乳甘露聚糖增加。尽管一些侵袭性曲霉病的体内研究也报道了棘白菌素治疗后侵袭性疾病和真菌负荷的其他标志物出现矛盾性增加,但这些观察结果并不一致。矛盾效应在临床上也未得到证实。因此,棘白菌素在高浓度下活性出现矛盾性减弱的临床意义仍不明确。对这一效应的全面了解可能会增进我们对真菌对棘白菌素细胞壁损伤反应的认识,并有可能改善治疗策略。

相似文献

1
Paradoxical echinocandin activity: a limited in vitro phenomenon?棘白菌素的矛盾活性:一种有限的体外现象?
Med Mycol. 2009;47 Suppl 1:S369-75. doi: 10.1080/13693780802428542. Epub 2009 Feb 28.
2
Attenuation of echinocandin activity at elevated concentrations: a review of the paradoxical effect.棘白菌素在高浓度时活性减弱:对矛盾效应的综述
Curr Opin Infect Dis. 2007 Dec;20(6):574-8. doi: 10.1097/QCO.0b013e3282f1be7f.
3
The Eagle-like effect of echinocandins: what's in a name?棘白菌素类的鹰样效应:名称中有何玄机?
Expert Rev Anti Infect Ther. 2013 Nov;11(11):1179-91. doi: 10.1586/14787210.2013.841543. Epub 2013 Oct 18.
4
Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches.棘白菌素类耐药性在念珠菌属中的研究进展:敏感性降低的机制与治疗方法。
Ann Pharmacother. 2012 Jul-Aug;46(7-8):1086-96. doi: 10.1345/aph.1R020. Epub 2012 Jul 17.
5
Echinocandin pharmacodynamics: review and clinical implications.棘白菌素类药物的药效动力学:综述及临床意义。
J Antimicrob Chemother. 2010 Jun;65(6):1108-18. doi: 10.1093/jac/dkq081. Epub 2010 Mar 23.
6
Influence of serum on in vitro susceptibility testing of echinocandins for Candida parapsilosis and Candida guilliermondii.血清对近平滑念珠菌和热带念珠菌体外药敏试验的影响。
Mycoses. 2012 Mar;55(2):156-60. doi: 10.1111/j.1439-0507.2011.02050.x. Epub 2011 Jun 12.
7
Echinocandin activity against Aspergillus spp. and the importance of pharmacodynamics.棘白菌素对曲霉属真菌的活性及药效学的重要性。
Med Mycol. 2009;47 Suppl 1:S376-81. doi: 10.1080/13693780802603698. Epub 2009 Mar 18.
8
Synergy of the antibiotic colistin with echinocandin antifungals in Candida species.抗生素黏菌素与棘白菌素类抗真菌药在念珠菌属中的协同作用。
J Antimicrob Chemother. 2013 Jun;68(6):1285-96. doi: 10.1093/jac/dks538. Epub 2013 Feb 1.
9
The echinocandins.棘白菌素类
Pharmacotherapy. 2007 Mar;27(3):369-88. doi: 10.1592/phco.27.3.369.
10
Synthesis and antifungal activity of ASP9726, a novel echinocandin with potent Aspergillus hyphal growth inhibition.ASP9726 的合成及抗真菌活性研究,一种新型棘白菌素,对曲霉菌丝生长有很强的抑制作用。
Bioorg Med Chem Lett. 2014 Feb 15;24(4):1172-5. doi: 10.1016/j.bmcl.2013.12.116. Epub 2014 Jan 6.

引用本文的文献

1
In Vitro Human Liver Model for Toxicity Assessment with Clinical and Preclinical Instrumentation.用于毒性评估的体外人肝模型及临床和临床前检测仪器
Pharmaceutics. 2024 Apr 29;16(5):607. doi: 10.3390/pharmaceutics16050607.
2
Crosstalk between the calcineurin and cell wall integrity pathways prevents chitin overexpression in Candida albicans.钙调神经磷酸酶和细胞壁完整性途径之间的串扰可防止白念珠菌中几丁质的过度表达。
J Cell Sci. 2021 Dec 15;134(24). doi: 10.1242/jcs.258889. Epub 2021 Dec 16.
3
Antifungal Susceptibility Testing: A Primer for Clinicians.
抗真菌药敏试验:临床医生入门指南。
Open Forum Infect Dis. 2021 Sep 9;8(11):ofab444. doi: 10.1093/ofid/ofab444. eCollection 2021 Nov.
4
Comparative Pharmacodynamics of Echinocandins against Aspergillus fumigatus Using an Pharmacokinetic/Pharmacodynamic Model That Correlates with Clinical Response to Caspofungin Therapy: Is There a Place for Dose Optimization?使用与卡泊芬净治疗临床反应相关的药代动力学/药效学模型比较棘白菌素对烟曲霉的药效学:剂量优化是否有空间?
Antimicrob Agents Chemother. 2021 Mar 18;65(4). doi: 10.1128/AAC.01618-20.
5
Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial.雷泽凡辛与卡泊芬净治疗念珠菌血症和侵袭性念珠菌病的 2 期随机、双盲研究:STRIVE 试验。
Clin Infect Dis. 2021 Dec 6;73(11):e3647-e3655. doi: 10.1093/cid/ciaa1380.
6
Transcriptional regulation of the caspofungin-induced cell wall damage response in Candida albicans.棘白菌素诱导的白念珠菌细胞壁损伤反应的转录调控。
Curr Genet. 2020 Dec;66(6):1059-1068. doi: 10.1007/s00294-020-01105-8. Epub 2020 Sep 2.
7
In vitro toxicity model: Upgrades to bridge the gap between preclinical and clinical research.体外毒性模型:升级以弥合临床前研究和临床研究之间的差距。
Bosn J Basic Med Sci. 2020 May 1;20(2):157-168. doi: 10.17305/bjbms.2019.4378.
8
Recent Insights into the Paradoxical Effect of Echinocandins.棘白菌素矛盾效应的最新见解
J Fungi (Basel). 2017 Dec 28;4(1):5. doi: 10.3390/jof4010005.
9
Dynamics of Mixed- Candida Species Biofilms in Response to Antifungals.混合念珠菌生物膜对抗真菌药物的反应动力学
J Dent Res. 2018 Jan;97(1):91-98. doi: 10.1177/0022034517729351. Epub 2017 Aug 29.
10
The Paradoxical Effect of Echinocandins in Aspergillus fumigatus Relies on Recovery of the β-1,3-Glucan Synthase Fks1.棘白菌素对烟曲霉的矛盾效应依赖于β-1,3-葡聚糖合酶Fks1的恢复。
Antimicrob Agents Chemother. 2017 Jan 24;61(2). doi: 10.1128/AAC.01690-16. Print 2017 Feb.